Latest news
Samsung Bioepis Files South Korea's First Approval for Biosimilar of Merck's $32.4 Billion Cancer Drug Keytruda - finance.biggo.comfinance.biggo.com · Mon, 10 Aug 2026 09:15:00 GMTBiotech Stocks: The New Drugs That Could Fuel Big Gains - Barron'sBarron's · Fri, 07 Aug 2026 15:30:00 GMTRevolution Medicines preps for pancreatic drug launch, boosting expected 2026 expenses - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 01:31:00 GMTBlossomHill Therapeutics Aims For $125 Million IPO On Cancer Treatment Pipeline Promise - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 14:42:32 GMTPfizer beats earnings estimates, targets $2.5 billion in additional cost cuts - ReutersReuters · Tue, 04 Aug 2026 18:21:51 GMTAstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports - CNBCCNBC · Sun, 02 Aug 2026 07:00:00 GMTGSK raises margin outlook, plots $2.5 billion restructuring to fast-track new drugs - ReutersReuters · Tue, 28 Jul 2026 07:00:00 GMT